Clinical Trials Update:&nbsp;Dec. 3, 2004
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
25501
(December 29, 2004) - Six clinical studies at the University of Rochester Medical Center have ended because of findings that question the safety of the drugs under investigation.
671952
THURSDAY, Jan. 27 (HealthDayNews) -- The results of a multi-center trial involving a quartet of drugs may bring fresh hope to patients battling advanced colorectal cancer, researchers reported Thursday.
93775
Encouraging phase II results of a trial to test the efficacy of a malaria vaccine for young children is published in this week&#39;s issue of THE LANCET (pp 1380, 1411).
592462
roundup Plus: PC shipments up, but revenue less so, study says...BEA mobilizes corporate data...Web services outfits merge...Microsoft sets holiday Xbox bundle...PalmSource settles Digeo patent suit.
500550
MONDAY, Dec. 11 (HealthDay News) -- A combination of three chemotherapy drugs -- pentostatin, cyclophosphamide and rituximab --  produced significant clinical response in patients with previously untreated chronic lymphocytic leukemia, according to a study presented Sunday at the American Society of Hematology annual meeting.
470908
Six months after the drug industry vowed to make its clinical trials more transparent, and three months after launching a common website to give the public "unprecedented access" to studies both good and bad, drug companies have posted unpublished trial results on the site for just five drugs.
70738
A new compound gives hope as the disease has become increasingly resistant to current drugs. By Thomas H. Maugh II / Los Angeles Times.
390422
FRIDAY, Nov. 17 (HealthDay News) -- Just-released data from a trial that was stopped early in 2004 for safety reasons is re-igniting debate on the safety of two popular painkillers.
612567
THURSDAY, Sept. 6 (HealthDay News) -- New studies from the first annual Breast Cancer Symposium shed light on racial differences in breast cancer, how not sticking with treatment can affect survival, and how nagging side effects cause people to stop their therapies.
283297
Researchers at Merck can use neural stem-cell tech in early stages of drug development. Plus: Pay for eggs OK in Britain. In Bodyhack.
118026
A clinical trial of the blockbuster arthritis drug Celebrex was shut down Friday after researchers found an increase in the risk of serious heart disease and strokes in those taking the drug.
712506
GlaxoSmithKline Plc announced further  clinical trial results on Sunday underlining the ability of a  drug combination including its product Tykerb to fight breast  cancer that has spread to the brain.
266095
The pharmaceutical industry made a commitment Thursday to publish more data about clinical drug trials, amid growing questions about the safety of many leading companies' medicines.
310131
Aventis, part of the sanofi-aventis Group (EURONEXT: SAN), announced today that The New England Journal of Medicine has published the results of two landmark phase III studies, which demonstrate that Taxotere (docetaxel) Injection Concentrate-based
466191
roundup Plus: .Mac customers suffer e-mail glitches...Alvarion expands wireless broadband in China...IBM launches business research group.
757229
Genzyme Corp. of Cambridge and German partner Bayer Schering Pharma AG said they have begun phase 3 trials of their cancer drug Campath to treat multiple sclerosis. The companies said they plan on reporting phase 2 results Oct. 14. After phase 3, they hope to seek US regulatory approval in 2011 to market the drug, also known as alemtuzumab, to ...